5，10，15，20-TETRAKIS[4-(TRIMETHYLAMMONIO)PHENYL]-21H，23H-PORPHINE TETRA-P-TOSYLATE SALT
博飞美科提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载
PA87357
PERFEMIKER
69458-20-4
C56H62N8+4.4[C7H8O3S]
1535.95
*注意事项:下单时请联系销售核实产品价格及货期，避免后续产生不便，感谢支持!
| 产品名称： |
卟啉,＞95% |
| 中文别名： |
5,10,15,20-四(4-三甲氨基)苯基卟啉四甲苯磺酸盐;卟啉 |
| 英文名称： |
5，10，15，20-TETRAKIS[4-(TRIMETHYLAMMONIO)PHENYL]-21H，23H-PORPHINE TETRA-P-TOSYLATE SALT |
| 英文别名： |
5,10,15,20-Tetrakis(4-(trimethylammonio)-phenyl)-21H,23H-porphine tetratosylate;4-methylbenzenesulfonate,trimethyl-[4-[10,15,20-tris[4-(trimethylazaniumyl)phenyl]-21,22-dihydroporphyrin-5-yl]phenyl]azanium;5,10,15,20-Tetrakis(4-trimethylammoniophenyl)porphyrin tetra(p-toluenesulfonate);Ttmapp;TTMAPP;4-methylbenzenesulfonate;trimethyl-[4-[10,15,20-tris[4-(trimethylazaniumyl)phenyl]-21,22-dihydroporphyrin-5-yl]phenyl]azanium;69458-20-4;DTXSID10475104 |
| 品牌： |
PERFEMIKER |
| CAS号： |
69458-20-4 |
| 分子式： |
C56H62N8+4.4[C7H8O3S] |
| 分子量： |
1535.95 |
| 纯度： |
＞95% |
| 详细描述： |
博飞美科的卟啉,＞95%为卟啉,产品稳定,定制速度快,极大地方便了广大科研客户的使用需求。产品包装为25mg。查询关键词:卟啉，69458-20-4，卟啉,＞95%，5，10，15，20-TETRAKIS[4-(TRIMETHYLAMMONIO)PHENYL]-21H，23H-PORPHINE TETRA-P-TOSYLATE SALT，博飞美科，Perfemiker，上海，厂家直销。 |
沪公网安备31011402010658号 
(Cl)Cl.ClC1C(%5bH%5d)%3dC(%5bH%5d)C(%3dC(%5bH%5d)C%3d1%5bH%5d)C1C2C(%5bH%5d)%3dC(%5bH%5d)C(%3dC(C3C(%5bH%5d)%3dC(%5bH%5d)C(%3dC(%5bH%5d)C%3d3%5bH%5d)Cl)C3%3dC(%5bH%5d)C(%5bH%5d)%3dC(C(C4C(%5bH%5d)%3dC(%5bH%5d)C(%3dC(%5bH%5d)C%3d4%5bH%5d)Cl)%3dC4C(%5bH%5d)%3dC(%5bH%5d)C(C(C5C(%5bH%5d)%3dC(%5bH%5d)C(%3dC(%5bH%5d)C%3d5%5bH%5d)Cl)%3dC5C(%5bH%5d)%3dC(%5bH%5d)C%3d1N5%5bH%5d)%3dN4)N3%5bH%5d)N%3d2+%7cc%3a21%2c78%2ct%3a53%2c72%7c)
%3ac(C3%3dCC%3dC(C)C%3dC3)%3ac3N4%5bNi%5dN5c%3a2C%3dCc5%3ac(C2%3dCC%3dC(C)C%3dC2)%3ac2%3an%3ac(%3ac(C5%3dCC%3dC(C)C%3dC5)%3ac4C%3dC3)C%3dC2)C%3dC1)
%3dCC%3d4)%3dC4C%3dCC(%5bN-%5d14)%3dC(C1C%3dCC(C)%3dCC%3d1)C1C%3dCC(N2%3d1)%3dC(C1C%3dCC(C)%3dCC%3d1)C1%3dCC%3dC(C%3d5C2C%3dCC(C)%3dCC%3d2)%5bN-%5d31)
%3dCC%3d4)%3dC4C%3dCC(%5bN-%5d14)%3dC(C1C%3dCC(Cl)%3dCC%3d1)C1C%3dCC(N2%3d1)%3dC(C1C%3dCC(Cl)%3dCC%3d1)C1%3dCC%3dC(C%3d5C2C%3dCC(Cl)%3dCC%3d2)%5bN-%5d31)